🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very excited to discuss our work on mAb priming agents for liquid biopsies!

This paper is really special. This was my first research project years ago, and it's amazing to finally see it out now in Nature Microbiology! Congratulations and big thanks to the whole team, especially Dylan Kotliar and @sidsraju! nature.com/articles/s4156…

Making blood tests for cancer detection more sensitive by making circulating tumor DNA stick around longer! Two nice strategies detailed in this paper from Massachusetts Institute of Technology (MIT) Broad Institute in Science Magazine

In an interview with Targeted Oncology, Shervin Tabrizi, MD, radiation oncologist, discussed the development of a 2-part priming strategy aimed at enhancing the sensitivity of liquid biopsies for cancer detection and monitoring. spklr.io/6016Wqdr

Final call! Don't miss out on our webinar discussing DNA-binding antibodies for sensitive liquid biopsies happening tomorrow, March 7th at 11:00 AM EST! Register today! hubs.li/Q02nnc7Z0 #Webinar #AntibodyEngineering #CancerDx #CancerDiagnostics #IVD

Missed our latest webinar? We’ve got you covered. Check out the recording of our latest webinar on developing sensitive liquid biopsies using antibodies as DNA-priming agents. Watch the recording here: hubs.li/Q02p5qcX0 #AntibodyEngineering #IVDs #CancerDiagnostics

In a cohort at average risk for colorectal cancer, a cell-free DNA blood-based test had 83% sensitivity for colorectal cancer, 90% specificity for advanced neoplasia, and 13% sensitivity for advanced precancerous lesions. Full ECLIPSE study results: nej.md/3v0J319

Our work on priming agents for #ctDNA liquid biopsies highlighted on National Cancer Institute Cancer Currents Blog! cancer.gov/news-events/ca…

For all #MedStudents applying for #RadOnc ☢️ this #Match2025 (or just curious about rad onc in general), we have an opportunity for you learn more about our program. Harvard Radiation Oncology Program Sign up today! forms.gle/rd5pb5X8DYKcZt… #ERAS #MedTwitter #MedEd

Very excited to share some of our work on priming agents for #cfDNA #LiquidBiopsies at the Next Generation Dx Summit this week!!

idea now happening. standing platform to accelerate ctDNA based clinical trials. Proud to be leading this! Mass General Cancer Center Science for America along side @ArielleMedford Scott Kopetz Van Morris, MD Arvind Dasari, MD, MS Neil H. Segal MD PhD Meredith Pelster Nikhil Wagle, MD (he/him) & others! nature.com/articles/s4156…

Did you see our #liquidbiopsy webinar series? Join us next week to move beyond theory into practical advice, guided by 9 expert speakers e.g. @antoniagage, Matthew Murray, Alastair Greystoke, Stefania Crucitta,Daniel Kim & Shervin Tabrizi, MD. Register Now! hubs.la/Q02VCLTf0

Very excited to share some of our work tomorrow Front Line Genomics #liquidbiopsy series!

Impressive report in NEJM. In a cohort of pregnant women with unusual clinical cfDNA-sequencing results, 52/107 were found to have a cancer via whole-body MRI, with a sensitivity of 98.0% and specificity of 88.5%. Physical exam & labs were of limited use. nejm.org/doi/full/10.10…

Modulating cell-free DNA biology as the next frontier in liquid biopsies dlvr.it/TH2DXg

Our paper describing the use of an ultrasensitive circulating tumour DNA detection assay to stratify #TRACERx patients with early-stage non-small cell lung cancer pre-operatively for clinical outcome is out today Nature Medicine. Thread below 👇

Excited to share our study describing a new liquid biopsy method called RARE-Seq for analyzing cell-free RNA (#cfRNA) that is out today in nature. 1/15 rdcu.be/eh1Nt

Congratulations to Iris Gibbs, MD, FASTRO; Helen Shih, MD, MS, MPH, FASTRO; & Joachim Yahalom, MD, FASTRO on their 2025 ASTRO Mentorship awards!! They will be recognized at #ASTRO25 in San Francisco. Stanford Radiation Oncology MassGeneral News Memorial Sloan Kettering Radiation Oncology ow.ly/A1cB50WlXIa